Industry news
-
30 May 2014
PR Newswire
The Intellectual Property & Science business of Thomson Reuters, the world leader in providing intelligent information to businesses and professionals, today announced the release of Overcoming Clinical Challenges in BRIC Markets, a report exploring the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and China.
-
27 May 2014
23.7 billion rubles to 11,175 skilled care for people suffering from rare diseases
Market Access Solutions
At the meeting of the expert working group of the Health Council of the Federation Council Committee on Social Policy was first presented the results of studies evaluating the necessary financial costs of drug supply patients with orphan diseases , the technique of ranking orphan diseases in the formulation and revision of the list , as well as the problems of regulation to ensure patients with " Orff states ." -
24 May 2014
Medvedev Instructs to Submit Proposals for Public Funding of Nuclear and Biomedicine
RIA Novosti
Russian Prime Minister Dmitry Medvedev has charged the Ministries of Health, Industry, Economic Development and Finance, in conjunction with development institutions, with submitting proposals to the government for public funding of measures to support the development of nuclear medicine and biomedical technologies in 2015-2017, according to a statement on the website of the Cabinet.
-
19 May 2014
Russian government tasked to saturate domestic market with its own drugs
ITAR TASS
“Our target is to start producing 90% of these essential medications inside the country till 2018,” the prime minister Dmitry Medvedev said
-
18 May 2014
RIA Novosti
Russian Prime Minister Dmitry Medvedev called a pharmaceutical community not only to manufacture vital drugs but to develop them locally.
-
18 May 2014
RIA Novosti
Russian Prime Minister Dmitry Medvedev entrusted Russian Ministry of Economic Development and Export Insurance Agency of Russia (EXIAR) to draft proposals on the support of exporters of domestic pharmaceutical and medical products.
-
18 May 2014
Proprietary super drugs will land in Russia
Elena Krivyakina, Komsomolskaya Pravda Newspaper
Head of the Russian Ministry of Health told that clinical development programs of novel drugs to combat lethal diseases are underway.
-
18 May 2014
Russia to stand a good chance for leading positions in the biotech field - Medvedev
Interfax
Russia stands a chance to take leading positions in the biotech field, Russian Prime Minister Dmitry Medvedev reckons.
-
17 May 2014
State to support exporters of medical and pharmaceutical products - Medvedev
Interfax
Russian Prime Minister Dmitry Medvedev entrusted the Russian Ministry of Economic Development and Trade to draft proposals on facilitation of Russian exporters of medical and pharmaceutical products through the Export Insurance Agency of Russia.
-
06 May 2014
LA BioMed woos deep pockets interested in its lifesaving research
Sandy Mazza, Daily Breeze
From iodine eyedrops that prevent blindness in children to cholesterol testing to early discoveries that led to in vitro fertilization, the Los Angeles Biomedical Research Institute has made innovative scientific breakthroughs with worldwide implications since 1962.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.